3rd Quarter - Report

MCDERMOTT WILL & SCHULTE LLP for GENOMIC HEALTH INC

Firm
Client
Income
$220,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.

LobbyistCovered position, as disclosed
EILEEN O'CONNOR —
PAUL WILLIAM RADENSKY —
SHEILA D WALCOFF Committee, U.S. House of Representatives
ERIC ZIMMERMAN —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Food & Drug Administration (FDA)

Health Issues HCR

FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests. Seeking TRICARE coverage for laboratory-developed tests.

LobbyistCovered position, as disclosed
CALVIN P JOHNSON —
EILEEN O'CONNOR —
PAUL WILLIAM RADENSKY —
SHEILA D WALCOFF Committee, U.S. House of Representatives
ERIC ZIMMERMAN —

Contacted: Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.

LobbyistCovered position, as disclosed
EILEEN O'CONNOR —
PAUL WILLIAM RADENSKY —
SHEILA D WALCOFF Committee, U.S. House of Representatives
ERIC ZIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.